DD216933A5 - Verfahren zur herstellung von 5-aminopyrimidin-4-on-verbindungen und ihren salzen - Google Patents
Verfahren zur herstellung von 5-aminopyrimidin-4-on-verbindungen und ihren salzen Download PDFInfo
- Publication number
- DD216933A5 DD216933A5 DD84265728A DD26572884A DD216933A5 DD 216933 A5 DD216933 A5 DD 216933A5 DD 84265728 A DD84265728 A DD 84265728A DD 26572884 A DD26572884 A DD 26572884A DD 216933 A5 DD216933 A5 DD 216933A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- general formula
- compound
- compounds
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838320505A GB8320505D0 (en) | 1983-07-29 | 1983-07-29 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD216933A5 true DD216933A5 (de) | 1985-01-02 |
Family
ID=10546495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD84265728A DD216933A5 (de) | 1983-07-29 | 1984-07-27 | Verfahren zur herstellung von 5-aminopyrimidin-4-on-verbindungen und ihren salzen |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0134096B1 (da) |
| JP (1) | JPS6051179A (da) |
| KR (1) | KR850001174A (da) |
| AT (1) | ATE40552T1 (da) |
| AU (1) | AU564650B2 (da) |
| CA (1) | CA1261831A (da) |
| CS (1) | CS244448B2 (da) |
| DD (1) | DD216933A5 (da) |
| DE (1) | DE3476541D1 (da) |
| DK (1) | DK368284A (da) |
| ES (1) | ES534620A0 (da) |
| FI (1) | FI842976A (da) |
| GB (1) | GB8320505D0 (da) |
| GR (1) | GR82226B (da) |
| HU (1) | HUT34743A (da) |
| IL (1) | IL72491A0 (da) |
| JO (1) | JO1327B1 (da) |
| NO (1) | NO843043L (da) |
| PT (1) | PT78977B (da) |
| ZA (1) | ZA845820B (da) |
| ZW (1) | ZW11584A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772704A (en) * | 1983-09-21 | 1988-09-20 | Bristol-Myers Company | 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity |
| GB8421427D0 (en) * | 1984-08-23 | 1984-09-26 | Smith Kline French Lab | Chemical compounds |
| US7423147B2 (en) | 2004-03-31 | 2008-09-09 | Janssen Pharmaceutical, N.V. | Pyridine compounds as histamine H3 modulators |
| CA2653940C (en) | 2006-05-30 | 2015-07-14 | Janssen Pharmaceutica N.V. | Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| CA2706328C (en) | 2007-11-20 | 2016-04-19 | Janssen Pharmaceutica N.V. | Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| EP4196793A1 (en) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN151188B (da) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
| ZA793443B (en) * | 1978-07-26 | 1980-12-31 | Glaxo Group Ltd | Heterocyclic derivatives |
| US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
| US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
| NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
-
1983
- 1983-07-29 GB GB838320505A patent/GB8320505D0/en active Pending
-
1984
- 1984-07-18 JO JO19841327A patent/JO1327B1/en active
- 1984-07-23 GR GR75407A patent/GR82226B/el unknown
- 1984-07-24 AU AU30991/84A patent/AU564650B2/en not_active Ceased
- 1984-07-24 CA CA000459505A patent/CA1261831A/en not_active Expired
- 1984-07-25 PT PT78977A patent/PT78977B/pt unknown
- 1984-07-25 IL IL72491A patent/IL72491A0/xx unknown
- 1984-07-25 AT AT84305045T patent/ATE40552T1/de not_active IP Right Cessation
- 1984-07-25 DE DE8484305045T patent/DE3476541D1/de not_active Expired
- 1984-07-25 EP EP84305045A patent/EP0134096B1/en not_active Expired
- 1984-07-26 FI FI842976A patent/FI842976A/fi not_active Application Discontinuation
- 1984-07-26 ES ES534620A patent/ES534620A0/es active Granted
- 1984-07-27 KR KR1019840004474A patent/KR850001174A/ko not_active Application Discontinuation
- 1984-07-27 ZW ZW115/84A patent/ZW11584A1/xx unknown
- 1984-07-27 NO NO843043A patent/NO843043L/no unknown
- 1984-07-27 DK DK368284A patent/DK368284A/da not_active Application Discontinuation
- 1984-07-27 JP JP59158537A patent/JPS6051179A/ja active Pending
- 1984-07-27 DD DD84265728A patent/DD216933A5/de unknown
- 1984-07-27 HU HU842902A patent/HUT34743A/hu unknown
- 1984-07-27 ZA ZA845820A patent/ZA845820B/xx unknown
- 1984-07-27 CS CS845810A patent/CS244448B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK368284D0 (da) | 1984-07-27 |
| ATE40552T1 (de) | 1989-02-15 |
| KR850001174A (ko) | 1985-03-16 |
| AU564650B2 (en) | 1987-08-20 |
| CS244448B2 (en) | 1986-07-17 |
| JPS6051179A (ja) | 1985-03-22 |
| ZA845820B (en) | 1985-06-26 |
| JO1327B1 (en) | 1986-11-30 |
| FI842976A0 (fi) | 1984-07-26 |
| ES8600254A1 (es) | 1985-09-16 |
| DK368284A (da) | 1985-01-30 |
| EP0134096A2 (en) | 1985-03-13 |
| PT78977B (en) | 1986-06-05 |
| NO843043L (no) | 1985-01-30 |
| EP0134096B1 (en) | 1989-02-01 |
| GB8320505D0 (en) | 1983-09-01 |
| HUT34743A (en) | 1985-04-28 |
| GR82226B (da) | 1984-12-13 |
| IL72491A0 (en) | 1984-11-30 |
| PT78977A (en) | 1984-08-01 |
| EP0134096A3 (en) | 1985-12-18 |
| ZW11584A1 (en) | 1985-04-17 |
| FI842976A (fi) | 1985-01-30 |
| DE3476541D1 (de) | 1989-03-09 |
| AU3099184A (en) | 1985-01-31 |
| ES534620A0 (es) | 1985-09-16 |
| CS581084A2 (en) | 1985-08-15 |
| CA1261831A (en) | 1989-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2614406C2 (da) | ||
| EP0877744B1 (de) | Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung | |
| EP0772604B1 (de) | Triazolverbindungen und deren verwendung als dopamin-d3-liganden | |
| DE2824781B2 (da) | ||
| DE2366625C2 (da) | ||
| EP0000220A1 (de) | Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| EP0185909B1 (de) | 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE69206725T2 (de) | Benzolsulfonamidderivate als 5-Lipoxygenasehemmer | |
| DE2819629A1 (de) | Alkylendiaminderivate, verfahren zu ihrer herstellung und ihre verwendung | |
| DE2333847A1 (de) | Tetrahydronaphthole, ihre salze und diese verbindungen enthaltende arzneimittel | |
| DD216933A5 (de) | Verfahren zur herstellung von 5-aminopyrimidin-4-on-verbindungen und ihren salzen | |
| DE69810560T2 (de) | Indanol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| DE3038593C2 (da) | ||
| CH642966A5 (en) | 1-(2-Chlorophenyl)-4-[2-(1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzox epin-1-yl)ethyl]piperazine and pharmacologically acceptable acid addition salts thereof | |
| EP0000395A1 (de) | 2-Piperazinotetraline, ihre Herstellung und Verwendung als Arzneimittel | |
| DE3027106C2 (da) | ||
| DE1445452A1 (de) | Neue Aminoaethoxyphenylamine und Verfahren zu ihrer Herstellung | |
| DE3223877C2 (da) | ||
| CH651027A5 (de) | Heterocyclische verbindungen, ihre herstellung und verwendung. | |
| DE69016857T2 (de) | Verfahren zur Herstellung von NiNi-Diakyl- 1,8-Naphthalendiamin. | |
| EP0796251B1 (de) | Uracilderivate | |
| DE69114644T2 (de) | 4(5)-Imidazole fähig zur Inhibierung von Aromatase. | |
| DE69301003T2 (de) | Hydroxylaminderivate | |
| DE3404193A1 (de) | 5-fluor-pyrimidin-2-yl-piperazin-verbindung, verfahren zu ihrer herstellung und pharmazeutische mittel | |
| DE69301681T2 (de) | Oximderivate |